factor XIII


Also found in: Dictionary, Medical, Legal, Financial, Encyclopedia, Wikipedia.
Related to factor XIII: Corifact
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for factor XIII

in the clotting of blood thrombin catalyzes factor XIII into its active form (fibrinase) which causes fibrin to form a stable clot

References in periodicals archive ?
[USPRwire, Wed Aug 21 2019] Factor XIII deficiency is a rare genetic blood disorder that is characterised by the deficiency of clotting factor XIII.
[ClickPress, Thu Jul 25 2019] The significant presence of communities that follow consanguineous marriages increases the risk of passing on factor XIII deficiency to the next generations, which is driving the factor XIII deficiency treatment market.
Burch, "The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography," Anesthesia & Analgesia, vol.
As factor XIII has a long half-life, prophylactic replacement therapy every 4 weeks with factor XIII concentrate or cryoprecipitate is effective as a preventive strategy.
(7,15) Besides this, SGH can be the first manifestation of underlying coagulopathy such as von Willebrand disease and factor XIII deficiency.
Objective: To provide a comprehensive literature review on roles of coagulation factor XIII (FXIII) in coagulation, wound healing, neoplasm, bone metabolism, and pregnancy.
Coagulation factor XIII (FXIII) is activated by thrombin into activated FXIII (FXIIIa).
Hoppe, "Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation," Thrombosis and Haemostasis, vol.
Determinacion de Factor XIII (Factor Estabilizador de la fibrina).
It converts fibrinogen to fibrin and activates factor XIII, platelets, and smooth muscle constriction (Biologies 2008;2:593-9).
Factor XIII (FXIII) deficiency is a rare (autosomal recessive) genetic disorder which is associated with delayed bleeding symptoms that occur hour or days after trauma.
Factor XIII (FXIII) is one of the main contributors to clot formation in the final stages of coagulation.
Although AHA is thus clinically and economically an important disorder, it is often unrecognized or misdiagnosed as other acquired hemorrhagic disorders, such as disseminated intravascular coagulation (DIC) and acquired inhibitors against von Willebrand factor (acquired von Willebrand syndrome [9]) and factor XIII (acquired factor XIII deficiency [10]).